Understanding comorbidity with depression and anxiety disorders

Journal of the American Osteopathic Association

Volumn 106, Issue 5 SUPPL., 2006, Pages

  Aina, Yemi ^a,b   Susman, Jeffrey L ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Combined Family Medicine Psychiatry Program ^*

^c Department of Family Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEMOGLOBIN A1C; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; RITONAVIR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANXIETY DISORDER; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG COST; DRUG SAFETY; ECONOMIC ASPECT; HEALTH CARE UTILIZATION; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR DEPRESSION; MENTAL DISEASE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RECURRENT DISEASE; RISK FACTOR; SEXUAL DYSFUNCTION; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; DEPRESSION; DIABETES MELLITUS; HEART DISEASE; OSTEOPATHIC MEDICINE; PSYCHOLOGICAL ASPECT; REVIEW;

ANXIETY DISORDERS; DEPRESSION; DIABETES MELLITUS; HEART DISEASES; HIV INFECTIONS; HUMANS; OSTEOPATHIC MEDICINE;

EID: 33746067189     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. Kroenke K, Spitzer R, Williams JB, Linzer M, Hahn SR, deGruy FV III, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3:774-79.
3. Weisberg R. Primary Care Anxiety Project. Presented at the 24th annual meeting of the Anxiety Disorders Association of America; March 11-14, 2004.
4. Lowe B, Spitzer RL, Grafe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord. 2004; 78(2):131-140.
5. Snaith R. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes. 2003;1(1):29.
6. Fawcett J, Kravitz HM. Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry. 1983;44(8 Pt 2):8-11.
7. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
8. Yonkers KA, Warshaw MG, Massion AO, Keller MB. Phenomenology and course of generalised anxiety disorder. Br J Psychiatry. 1996;168:308-313.
9. Van Ameringen M, Mancini C, Styan G, Donison D. Relationship of social phobia with other psychiatric illness. J Affect Disord. 1991;21(2):93-99.
10. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
11. Kessler RC, Ormel J, Demler O, Stang PE. Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J Occup Environ Med. 2003;45:1257-1266.
12. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Arch Gen Psychiatry. 2005;62:617-627. Erratum in: Arch Gen Psychiatry. 2005;62:709.
13. Stein MB, Roy-Byrne PP, Craske MG, Bystritsky A, Sullivan G, Pyne JM, et al. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care. 2005;43:1164-1170.
14. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999;56:617-626.
15. Keller MB, Hanks DL. Anxiety symptom relief in depression treatment outcomes. J Clin Psychiatry. 1995;56(suppl 6):22-29.
16. Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet. 2006;367:153-167.
17. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med. 2003;65:201-210.
18. Frazure-Smith N, Lesperance F, Talajiic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA. 1993;270:1819-1825. Erratum in JAMA. 1994;271:1082.
19. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhulsen DJ, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66:814-822.
20. Roose S, Laghrissi-Thode F, Kennedy JA, Nelson JC, Bigger JT Jr, Pollock BG, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 1998;279:287-291.
21. Glassman A, O'Connor C, Califf R, Swedberg K, Schwartz P, Bigger JT Jr, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701-709.
22. Joynt K, O'Connor CM. Lessons from SADHART, ENRICHD, and other trials. Psychosom Med. 2005;67(suppl 1):S63-S66.
23. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161:1849-1856.
24. Kubzansky LD, Cole SR, Kawachi I, Vokonas P, Sparrow D. Shared and unique contributions of anger, anxiety, and depression to coronary heart disease: a prospective study in the normative aging study. Ann Behav Med. 2006;31:21-29.
25. Strik JJ, Denollet J, Lousberg R, Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol. 2003;42:1801-1807.
26. Grigsby AB, Anderson RJ, Freedland KF, Couse FE, Lustman PJ. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res. 2002;53:1053-1060.
27. Thomas AJ, Kalaria RN, O'Brien JT. Depression and vascular disease: what is the relationship? J Affect Disord. 2004;79(1-3):81-95.
28. Lustman P, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000:23:934-942.
29. Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care. 1999;22:1071-1076.
30. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998;129:613-621.
31. Treisman G, Fishman M, Schwartz J, Hutton H, Lyketsos C. Mood disorders in HIV infection. Depress Anxiety. 1998;7:178-187.
32. Sareen J, Cox BJ, Clara I, Asmundson GJ. The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey. Depress Anxiety. 2005;21:193-202.
33. McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain. 2004;111(1-2):77-83.
34. Mort JR. Selective serotonin reuptake inhibitors (SSRIs) and falls in the elderly depressed patient. S D J Med. 1999;52(6):201-202.
35. Pollock BG. Adverse reactions of antidepressants in elderly patients. J Clin Psychiatry. 1999;60(suppl 20):4-8.
36. Kennedy N, Foy K. The impact of residual symptoms on outcome of major depression. Curr Psychiatry Rep. 2005;7:441-446.
37. DeBattista C, Lembke A. Update on augmentation of antidepressant response in resistant depression. Curr Psychiatry Rep. 2005;7:435-440.
38. Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004;61:1042-1049.
39. Burt VK. Plotting the course to remission: the search for better outcomes in the treatment of depression. J Clin Psychiatry. 2004;65(suppl 12):20-25.